These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33227368)

  • 41. Alterations in growth-associated protein (GAP-43) expression in lower urinary tract pathways following chronic spinal cord injury.
    Vizzard MA
    Somatosens Mot Res; 1999; 16(4):369-81. PubMed ID: 10632033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of local microinjection of selective dopamine D1 and D2 receptor agonists and antagonists into the dorsal raphe nucleus on sleep and wakefulness in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2018 Feb; 339():11-18. PubMed ID: 29137945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The intermediolateral cell column of the thoracic spinal cord is comprised of target-specific subnuclei: evidence from retrograde transport studies and immunohistochemistry.
    Appel NM; Elde RP
    J Neurosci; 1988 May; 8(5):1767-75. PubMed ID: 2896766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of dopamine in prepulse inhibition of acoustic startle.
    Zhang J; Forkstam C; Engel JA; Svensson L
    Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation.
    Zhao H; Zhu W; Pan T; Xie W; Zhang A; Ondo WG; Le W
    J Neurosci Res; 2007 Apr; 85(5):1065-76. PubMed ID: 17342757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid modification of spinal dopamine receptor activation by apomorphine.
    Hall ED; Tyler CV
    Brain Res; 1983 May; 267(2):380-3. PubMed ID: 6307470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of AMPA currents by D(1)-like but not D(2)-like receptors in spinal motoneurons.
    Han P; Whelan PJ
    Neuroscience; 2009 Feb; 158(4):1699-707. PubMed ID: 19110039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones.
    Fleetwood-Walker SM; Hope PJ; Mitchell R
    J Physiol; 1988 May; 399():335-48. PubMed ID: 2841456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initiating or blocking locomotion in spinal cats by applying noradrenergic drugs to restricted lumbar spinal segments.
    Marcoux J; Rossignol S
    J Neurosci; 2000 Nov; 20(22):8577-85. PubMed ID: 11069966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circadian phase-dependent modulation of cGMP-gated channels of cone photoreceptors by dopamine and D2 agonist.
    Ko GY; Ko ML; Dryer SE
    J Neurosci; 2003 Apr; 23(8):3145-53. PubMed ID: 12716922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D2 dopamine receptor involvement in spinal dopamine-produced antinociception.
    Liu QS; Qiao JT; Dafny N
    Life Sci; 1992; 51(19):1485-92. PubMed ID: 1435058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. D1 receptors modulate striatal dopamine release induced by the stimulation of both D1 and D2 receptors: in vivo voltammetric data revisited.
    Fechtali T; Issoual D; Abraini JH
    J Physiol Paris; 1994; 88(5):331-3. PubMed ID: 7787831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons.
    Alberto CO; Trask RB; Quinlan ME; Hirasawa M
    J Neurosci; 2006 Sep; 26(39):10043-50. PubMed ID: 17005867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentration-dependent activation of dopamine receptors differentially modulates GABA release onto orexin neurons.
    Linehan V; Trask RB; Briggs C; Rowe TM; Hirasawa M
    Eur J Neurosci; 2015 Aug; 42(3):1976-83. PubMed ID: 26036709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of spinal dopamine receptors in mediation of the hypotensive and bradycardic effects of systemic quinpirole in anaesthetised rats.
    Lahlou S
    Eur J Pharmacol; 1998 Jul; 353(2-3):227-37. PubMed ID: 9726652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis.
    Vizzard MA; Boyle MM
    Brain Res; 1999 Oct; 844(1-2):174-87. PubMed ID: 10536274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice.
    Hsu KS
    J Neurophysiol; 1996 Sep; 76(3):1887-95. PubMed ID: 8890301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine receptors influence vasoactive intestinal peptide release from turkey hypothalamic explants.
    Chaiseha Y; Youngren OM; el Halawani ME
    Neuroendocrinology; 1997 Jun; 65(6):423-9. PubMed ID: 9208404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.